Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter]

被引：0
|
作者：
Paul Begovatz
Alessandra Bierwagen
Jesper Lundbom
Michael Roden
机构：
[1] Leibniz Center for Diabetes Research at Heinrich Heine University,Institute for Clinical Diabetology, German Diabetes Center
[2] Heinrich Heine University Düsseldorf,Department of Endocrinology and Diabetology, Medical Faculty
来源：
Diabetologia | 2015年 / 58卷
关键词：
Beta cell; Ectopic fat; Insulin sensitivity; Lipids; Magnetic resonance imaging; Pancreas; Pancreatic steatosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2679 / 2681
页数：2
相关论文
共 50 条
  • [21] Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al [letter]
    Sandra Hummel
    Nadine Friedl
    Christiane Winkler
    Anette-G. Ziegler
    Peter Achenbach
    Diabetologia, 2023, 66 : 2389 - 2390
  • [22] Intensified glucose lowering in type 2 diabetes. Reply to Czupryniak L, SzymaA"ska-Garbacz E, Pawowski M et al. [letter], Aizawa T and Funase Y [letter] and DeVries JH [letter]
    Yudkin, J. S.
    Richter, B.
    Gale, E. A. M.
    DIABETOLOGIA, 2011, 54 (03) : 707 - 708
  • [23] Reply to the comment of Ursini et al. "Retrospective analysis of type 2 diabetes. Prevalence in a systemic sclerosis cohort from southern Italy"
    Tseng, Chia-Chun
    Chang, Shun-Jen
    Tsai, Wen-Chan
    Ou, Tsan-Teng
    Wu, Cheng-Chin
    Sung, Wan-Yu
    Hsieh, Ming-Chia
    Yen, Jeng-Hsien
    JOINT BONE SPINE, 2016, 83 (05) : 613 - 613
  • [24] Intensified glucose lowering in type 2 diabetes. Reply to Czupryniak L, Szymańska-Garbacz E, Pawłowski M et al. [letter], Aizawa T and Funase Y [letter] and DeVries JH [letter]
    J. S. Yudkin
    B. Richter
    E. A. M. Gale
    Diabetologia, 2011, 54 : 707 - 708
  • [25] Waist circumference gain compared with waist circumference as predictors of type 2 diabetes risk - Reply to G Heinz et al
    Wang, YF
    Rimm, EB
    Stampfer, MJ
    Willett, WC
    Hu, FB
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (05): : 1135 - 1135
  • [26] ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter]
    D. R. Matthews
    S. E. Inzucchi
    Diabetologia, 2012, 55 : 2856 - 2857
  • [27] ADA/EASD position statement of the treatment of type 2 diabetes: Reply to Rodbard HW and Jellinger PS [letter], Scheen AJ [letter] and Ceriello A, Gallo M, Gentile S et al [letter]
    Matthews, D. R.
    Inzucchi, S. E.
    DIABETOLOGIA, 2012, 55 (10) : 2856 - 2857
  • [28] Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter]
    Lean, Michael E. J.
    Taylor, Roy
    Sattar, Naveed
    DIABETOLOGIA, 2023, 66 (05) : 958 - 959
  • [29] Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter]
    Michael E. J. Lean
    Roy Taylor
    Naveed Sattar
    Diabetologia, 2023, 66 : 958 - 959
  • [30] Author Reply to Letter to the Editor: In Response to: Comment on Sutton et al.'s "Allopurinol and the Risk of Diabetic Macular Edema among US Veterans with Type 2 Diabetes"
    Sutton, S. Scott
    Magagnoli, Joseph
    Cummings, Tammy H. H.
    Hardin, James W. W.
    Ambati, Jayakrishna
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (07) : 1454 - 1456
12345